Physician profile
David A Kon
NPI 1407040454
$12,381.23
in general payments reported to CMS, 2019-2025
33 companies · $3,336 in 2025
The $3,336 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.41 · 2021: $1,375 · 2022: $1,819 · 2023: $2,821 · 2024: $3,016 · 2025: $3,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,963 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,962.94 |
| Education | $209.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,067.37 | 2021-2025 | |
| Janssen Biotech, INC. | $1,266.11 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Leo Pharma INC. | $1,242.98 | 2021-2025 | Adbry, Anzupgo |
| Incyte Corporation | $948.89 | 2021-2025 | Opzelura |
| Genzyme Corporation | $875.43 | 2021-2025 | |
| Galderma Laboratories, L.P. | $716.40 | 2021-2025 | Aklief, Nemluvio, Oracea |
| Pfizer INC. | $635.05 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $532.57 | 2023-2025 | Sotyktu |
| Amgen INC. | $479.18 | 2021-2025 | Otezla, Enbrel, Otezla |
| Dermavant Sciences, INC. | $465.42 | 2022-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $460.87 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $412.50 | 2021-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $372.52 | 2021-2024 | Winlevi, Absorica Ld |
| Ucb, INC. | $278.17 | 2021-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $205.37 | 2022-2025 | Taltz, Ebglyss, Olumiant |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $204.72 | 2021-2025 | Jublia, Cabtreo, Arazlo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.67 | 2022-2025 | Spevigo |
| Strata Skin Sciences, INC. | $158.36 | 2023-2025 | Xtrac |
| Organon LLC | $155.70 | 2025 | Vtama, Nexplanon |
| Mayne Pharma Commercial LLC | $128.97 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $116.46 | 2021 | |
| Arcutis Biotherapeutics, INC. | $101.02 | 2023-2025 | Zoryve |
| Almirall LLC | $62.68 | 2021-2025 | Klisyri |
| Sanofi-Aventis U.S. LLC | $61.96 | 2021 | |
| Medimetriks Pharmaceuticals, INC. | $55.42 | 2022-2024 | Clindacin Etz |
| Journey Medical Corporation | $51.37 | 2022-2025 | |
| Botanix Sb INC | $25.37 | 2025 | Sofdra |
| Convatec INC. | $19.09 | 2024 | |
| Dermira, INC. | $18.77 | 2021 | |
| Paratek Pharmaceuticals, INC. | $18.57 | 2024 | Nuzyra |
| Helsinn Therapeutics (U.S.), INC. | $16.62 | 2023 | Valchlor |
| Sensus Healthcare, INC. | $14.41 | 2020 | |
| Biofrontera INC. | $10.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.